Johns Hopkins Medicine (based in Baltimore, Maryland) is launching a new psychedelic research center where scientists will test the potential of so-called magic mushrooms and other drugs to treat some of the toughest mental health and addiction challenges.
It is believed to be the first center in the United States and the largest in the world to focus on drugs still better known as symbols of 1960s counterculture than serious medicine.
Psychedelics are a class of drugs that produce unique and profound changes of consciousness over the course of several hours.
The Center for Psychedelic and Consciousness Research is going to focus on how psychedelics affect behavior, brain function, learning and memory, the brain’s biology, and mood.
The Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine is being funded by a $17 million donation from a group of private donors. Since federal funding cannot be used for such research, the center needs private support.
The Hopkins center’s research will focus on applications of the drugs for treating opioid addiction, Alzheimer’s disease, post-traumatic stress disorder, eating disorders and depression, among other diseases.